Robert Salisbury, PhD, professor emeritus of political science in Arts & Sciences and an expert on how lobbyists and interest groups work inside the Beltway, died April 9, 2010. He was 79.
He’s Canadian, he plays hockey, and he’s had a brush with Olympic glory. Physician-scientist Gregory D. Longmore, MD, investigates problems relevant to cancer onset and metastasis.
Six outstanding individuals will receive the 2010 Gerry and Bob Virgil Ethic of Service Award at 5:30 p.m. Thursday, April 15, in the Knight Center. Founded during the Sesquicentennial year in 2003-04, the Ethic of Service award annually recognizes select members of the university community who exemplify a character of service and giving to the St. Louis region.
WHAT: The 20th annual Pow Wow at Washington University, a festival of American Indian cultures WHEN: Saturday, April 10 from noon to 10 p.m. Grand entries of dancers will be showcased at 1 and 6 p.m. Arts & crafts booths will open at 10 a.m. WHERE: Washington University’s Athletic Center, near the intersection of Forsyth […]
I. Jerome Flance, MD, a renowned physician, educator and pulmonary disease specialist at Washington University School of Medicine since the 1940s, died Friday, April 2, 2010, at Barnes-Jewish Hospital. He was 98.
As told by WUSTL alumna Stacey Robertson Maurice And then John Evans, the brave man that he is, walked out on the spit to one side of the cove, the waves crashing over his legs. He got out far enough that he was past the worst of the breakers, and then the Zodiac with the […]
Of note Hugh Macdonald, the Avis H. Blewett Professor of Music in Arts & Sciences, received a gold medal from La Renaissance Française April 1 at the French Embassy in Washington, D.C. Macdonald was honored for his scholarship on 19th-century French composers Hector Berlioz, Jules Massenet, Edouard Lalo and Emmanuel Chabrier as well as his […]
A five-year, $3.7 million clinical trial will investigate how to balance the benefits and risks of warfarin, a drug that helps prevent potentially deadly blood clots. The multicenter study, led by researchers at Washington University School of Medicine in St. Louis, will evaluate customized warfarin dosage based on patient genetics and will test which range of blood clotting is optimal in orthopedic patients.